Rituximab for the treatment of Churg-Strauss syndrome with renal involvement
Volume: 26, Issue: 9, Pages: 2865 - 2871
Published: Feb 16, 2011
Abstract
Churg-Strauss syndrome (CSS) is a small vessel systemic vasculitis associated with asthma and eosinophilia that causes glomerulonephritis (GN) in ∼25% of patients. Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that depletes B cells and is effective in numerous autoimmune diseases including antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. We aim to evaluate the safety and efficacy of RTX in inducing remission of...
Paper Details
Title
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement
Published Date
Feb 16, 2011
Volume
26
Issue
9
Pages
2865 - 2871
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History